Mechanism: Sphingomyelin metabolism in erythrocyte membrane in asthma

Journal of Asthma

Volumn 47, Issue 9, 2010, Pages 966-971

  Gupta, Prachi ^a   Vijayan, Vannan Kandi ^a   Bansal, Surendra Kumar ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

asthma; lipid rafts; membranes; phospholipids; sphingomyelin; sphingomyelinase

Indexed keywords

CHOLESTEROL; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; PHOSPHOLIPID;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; HUMAN CELL; LIPID RAFT; MALE; PHOSPHOLIPID METABOLISM; ADOLESCENT; BLOOD; CELL MEMBRANE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; ASTHMA; CHOLESTEROL; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; MALE; MEMBRANE MICRODOMAINS; MIDDLE AGED; PHOSPHOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; YOUNG ADULT;

EID: 78149433636     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770903.2010.517590     Document Type: Article

References (41)

1. Ramstedt B, Slotte JP. Membrane properties of sphingomyelins. FEBS Lett 2002; 37:531-533.
2. Ishitsuka R, Yamaji-Hasegawa A, Makino A, Hirabayashiy Y, Kobay ashi TA. Lipid-specific toxin reveals heterogeneity of sphingomyelincontaining membranes. Biophys J 2004; 86:296-307.
3. Richard AZ. Sphingomyelinase and membrane sphingomyelin content: determinants of proximal tubule cell susceptibility to injury. J Am Soc Nephrol 2000; 11:894-902.
4. Lund-Katz S, Laboda HM, McLean LR, Phillips MC. Influence of molecular packing and phospholipid type rates of cholesterol exchange. Biochem 1988; 27:3416-3423.
5. Rietveld A, Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys Acta 1998; 1376:467-479.
6. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14:111-136.
7. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1:31-39.
8. Haks MC, Belkowski SM, Ciofani M, Rhodes M, Lefebvre JM, Trop S. Low activation threshold as a mechanism for ligand-independent signaling in pre-T cells. J Immunol 2003; 170:2853-2861.
9. Guo B, Kato RM, Garcia LM, Wahl MI, Rawlings DJ. Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 2000; 13:243-523.
10. de Mello Coelho V, Nguyen D, Giri B, Bunbury A, Schaffer E, Taub DD. Quantitative differences in lipid raft components between murine CD4+ and CD8+ T cells. BMC Immunol 2004; 5:2.
11. Gombos I, Detre C, Vamosi G, Matko J. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for Tcell activation and immunological synapse formation. Immunol Lett 2004; 92:117-124.
12. Friedl P, Storim J. Diversity in immune-cell interactions: states and functions of the immunological synapse. Trends Cell Biol 2004; 14:557-567.
13. Lou Z, Jevremovic D, Billadeau DD, Leibson PJ. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med 2000; 191:347-354.
14. Holowka D, Baird B. Fc(epsilon)RI as a paradigm for a lipid raftdependent receptor in hematopoietic cells. Semin Immunol 2001; 13:99-105.
15. Rosenberger CM, Brumell JH, Finlay BB. Microbial pathogenesis: lipid rafts as pathogen portals. Curr Biol 2000; 10:R823-R825.
16. Gombos I, Kiss E, Detre C, Laszlo G, Matko J. Cholesterol and sphingolipids as lipid organizers of the immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death. Immunol Lett 2006; 104: 59-69.
17. Palestini P, Calvi C, Conforti E, Daffara R, Botto L, Miserocchi G. Compositional changes in lipid microdomains of air blood barrier plasma membranes in pulmonary interstitial edema. J Appl Physiol 2003; 95:1446-1452.
18. Schmidt D, Rabe KF. Immune mechanism of smooth muscle hyperreactivity in asthma. J Allergy Clin Immunol 2000; 105:673-682.
19. Costello RW, Fryer AD. Cholinergic mechanisms in asthma. In: Barnes PJ, Grustein MM, Left AR, Woolcoch AJ, eds. Asthma. Volume 1. Philadelphia: Lippincort-Raven publishers, 1997:965-984.
20. Bai TR. Role of β2 adrenergic receptors. In: Barnes PJ, Grunstein MM, Left AR, Woolcoch AJ, eds. Asthma. Volume 1. Philadelphia: Lippincort-Raven publishers, 1997:985-995.
21. Bass DA. Intracellular signalling mechanism. The second messengers. In: Barnes PJ, Grunstein MM, Left AR, Woolcoch AJ, eds. Asthma. Philadelphia: Lippincort- Raven publishers, 1997; 1: 313-335.
22. James PW, Ley SC, Magee AI. Aggregation of lipid rafts accompanies signalling via the T cell-antigen receptor. J Cell Biol 1999; 147: 447-461.
23. Kanfer JN. The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue. J Biol Chem 1966; 241:1081-1084.
24. Chatterjee S. Neutral sphingomyelinase: past, present and future. Chem Phys Lipids 1999; 102(1-2):79-96.
25. Uhlig S, Gulbins E. Sphingolipids in the lungs. Am J Respir Crit Care Med 2008; 178(11):1100-1114.
26. Nixon GF. Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 2009; 158(4): 982-993.
27. Todoriko LD. Changes in the morphofunctional state of the erythrocyte membranes in bronchial asthma in patients of different ages. Lik Sprava 1998; 2:51-54.
28. Mineev VN, Shpetnaia EA, Shadrin EB. Membrane receptor disorders in bronchial asthma. Ter Arkh 1999; 71:9-13.
29. Zhikharev SS, Pertseva MN, Kuznetsova LA, Mineev VN, Iablonskaia VN. Level of specific binding of beta-adrenergic ligands and the morphofunctional properties of erythrocytes in bronchial asthma. Ter Arkh 1988; 60:89-93.
30. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. National Institutes of Health. National Heart, Lung and Blood Institute Information Center: Bethesda, 1997.
31. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scandinavian J Immunol Suppl 1976; 5:9-15.
32. Herbert GR, Oklander M. Improved procedure for the extraction of lipids from human erythrocytes, J. LIPID RES. 1965; 6:428-431.
33. Zak B, Dickenman RC, White EG, Burnett H, Cherney PJ. Rapid estimation of free and total cholesterol. Am J Clin Pathol 1954; 24:1307-1315.
34. Misra UK. Thin layer chromatographic estimation of rat plasma and tissue lipids. Biochem Biol Sper 1968; 7:57-59.
35. Korte K, Casey ML. Phospholipid and neutral lipid separation by one-dimensional thin-layer chromatography. J Chromatography 1982; 232:47-53.
36. Hanahan DJ, Ekholm JE. The preparation of red cell ghosts (membranes) In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. Vol. XXXI. New York: Academic Press 1974: 168-172.
37. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 193:265-275.
38. Suzuki K. Enzymic diagnosis of sphingolipidoses. In: Colowick SP, Kaplan NO, eds. Method in Ezymology. Vol. 50. New York: Academic Press 1978:456-488.
39. Sahu S, Lynn WS. Lipid composition of sputum from patients with asthma and patients with cystic fibrosis. Inflammation 1978; 3(1): 27-36.
40. Albi E, Peloso I, Magni MV. Nuclear membrane sphingomyelin- cholesterol changes in rat liver after hepatectomy. Biochem Biophys Res Commun 1999; 262:692-695. (Pubitemid 29443720)
41. Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002; 110:597-603.